These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3487504)

  • 21. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
    Price GE; Ou R; Jiang H; Huang L; Moskophidis D
    J Exp Med; 2000 Jun; 191(11):1853-67. PubMed ID: 10839802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytolytic T-lymphocyte response to isolated class I H-2 proteins and influenza peptides.
    Kane KP; Vitiello A; Sherman LA; Mescher MF
    Nature; 1989 Jul; 340(6229):157-9. PubMed ID: 2786997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo administration of major histocompatibility complex class I-specific peptides from influenza virus induces specific cytotoxic T cell hyporesponsiveness.
    Müllbacher A; Tha Hla R
    Eur J Immunol; 1993 Oct; 23(10):2526-31. PubMed ID: 8405053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.
    Fu TM; Ulmer JB; Caulfield MJ; Deck RR; Friedman A; Wang S; Liu X; Donnelly JJ; Liu MA
    Mol Med; 1997 Jun; 3(6):362-71. PubMed ID: 9234241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal tolerance of major histocompatibility complex antigens alters Ir gene control of the cytotoxic T cell response to vaccinia virus.
    Müllbacher A; Blanden RV; Brenan M
    J Exp Med; 1983 Apr; 157(4):1324-38. PubMed ID: 6220111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus.
    Gao XM; Liew FY; Tite JP
    J Immunol; 1989 Nov; 143(9):3007-14. PubMed ID: 2478631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
    Falk K; Rötzschke O; Deres K; Metzger J; Jung G; Rammensee HG
    J Exp Med; 1991 Aug; 174(2):425-34. PubMed ID: 1713253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T cells recognize fragments of the influenza nucleoprotein.
    Townsend AR; Gotch FM; Davey J
    Cell; 1985 Sep; 42(2):457-67. PubMed ID: 2411422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection.
    Tite JP; Hughes-Jenkins C; O'Callaghan D; Dougan G; Russell SM; Gao XM; Liew FY
    Immunology; 1990 Oct; 71(2):202-7. PubMed ID: 2172156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competition between unrelated peptides recognized by H-2-Kd restricted T cells.
    Pala P; Bodmer HC; Pemberton RM; Cerottini JC; Maryanski JL; Askonas BA
    J Immunol; 1988 Oct; 141(7):2289-94. PubMed ID: 2459204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness.
    Zinkernagel RM; Althage A; Cooper S; Kreeb G; Klein PA; Sefton B; Flaherty L; Stimpfling J; Shreffler D; Klein J
    J Exp Med; 1978 Aug; 148(2):592-606. PubMed ID: 212503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens.
    Fu TM; Guan L; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
    Vaccine; 1998 Nov; 16(18):1711-7. PubMed ID: 9778746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant.
    Ohlén C; Bastin J; Ljunggren HG; Foster L; Wolpert E; Klein G; Townsend AR; Kärre K
    J Immunol; 1990 Jul; 145(1):52-8. PubMed ID: 2358681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products.
    Wysocka M; Bennink JR
    Cell Immunol; 1988 Apr; 112(2):425-9. PubMed ID: 3258552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation.
    Wraith DC; Askonas BA
    J Gen Virol; 1985 Jun; 66 ( Pt 6)():1327-31. PubMed ID: 3874261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes.
    Vitiello A; Heath WR; Sherman LA
    J Immunol; 1989 Sep; 143(5):1512-7. PubMed ID: 2474602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
    Oukka M; Riché N; Kosmatopoulos K
    J Immunol; 1994 May; 152(10):4843-51. PubMed ID: 8176207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR; Smith GL; Moss B
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1785-9. PubMed ID: 3872457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
    Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
    J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.